Diastolic heart failure is a new clinical entity of trastuzumab-induced cardiotoxicity: a case report

BACKGROUND: Cancer therapy-related cardiac dysfunction (CTRCD) is defined as a decrease in the left ventricular ejection fraction (LVEF) of >10% to a value below the lower limit of normal or relative reduction in global longitudinal strain (GLS) >15% from baseline after cancer treatment. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kana, Matsumoto, Kensuke, Kishi, Atsuhiko, Kawasaki, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792275/
https://www.ncbi.nlm.nih.gov/pubmed/36582596
http://dx.doi.org/10.1093/ehjcr/ytac470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792275/
https://www.ncbi.nlm.nih.gov/pubmed/36582596
http://dx.doi.org/10.1093/ehjcr/ytac470

Ejemplares similares